EXCLUSIVE LICENSE AND RESEARCH COLLABORATION AGREEMENT by and between COCRYSTAL PHARMA, INC. and MERCK SHARP & DOHME CORP.License and Research Collaboration Agreement • April 1st, 2019 • Cocrystal Pharma, Inc. • Pharmaceutical preparations • New York
This Agreement (this “Agreement”) is effective as of January 2, 2019 (the “Effective Date”), and is entered into by and between Cocrystal Pharma, Inc., a corporation organized and existing under the laws of Delaware (“Cocrystal”) and Merck Sharp & Dohme Corp., a corporation organized and existing under the laws of New Jersey (“Merck”).
